MyFinsight
Home
About
Contact
qdel: the income statement
Download
Download image
Net loss
-$733,000K
(-3583.42%↓ Y/Y)
(benefit from) provision
for income taxes
-$23,900K
(-168.54%↓ Y/Y)
Loss before income
taxes
-$756,900K
(-2528.13%↓ Y/Y)
Molecular Diagnostics
$4,800K
Point Of Care
$164,600K
Donor Screening
$14,700K
Immunohematology
$142,000K
(7.58%↑ Y/Y)
Labs
$373,800K
(5.03%↑ Y/Y)
Other expense, net
-$900K
(0.00%↑ Y/Y)
Loss on
extinguishment of debt
-$5,100K
Interest expense, net
$46,100K
(207.46%↑ Y/Y)
Operating (loss) income
-$704,800K
(-4798.67%↓ Y/Y)
Total revenues
$699,900K
(-3.74%↓ Y/Y)
Other operating
expenses
$14,300K
(126.98%↑ Y/Y)
Asset impairment
charge
$9,700K
Goodwill impairment
charge
$700,700K
Restructuring, integration and
other charges
$39,600K
Amortization of intangible
assets
$47,700K
(-8.09%↓ Y/Y)
Research and development
$41,500K
(-25.76%↓ Y/Y)
Selling, marketing and
administrative
$186,900K
(0.27%↑ Y/Y)
Cost of sales,
excluding amortization of...
$364,300K
(-2.80%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
QuidelOrtho Corp (QDEL)
QuidelOrtho Corp (QDEL)